Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY2586116 in Obstructive Sleep Apnea
NCT05527457Phase 1Completed
- Sponsor
- Flinders University
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BAY2586116 in obstructive sleep apnea (OSA) (3 arms), sponsored by Flinders University. Primary endpoint: Individual comparison between physiology changes in Pcrit during KOALA part A and change in AHI with BAY2586116 vs. placebo at 1 week. Started Aug 2022; status: completed.
02
Drugs
BAY2586116
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05527457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05527457.